Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rifaximin Versus Norfloxacin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis

NCT04159870 is registered in ClinicalTrials.gov with Ospedali Riuniti di Foggia as lead sponsor.

NCT NCT04159870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04159870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rifaximin Versus Norfloxacin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis
Lead sponsor
Ospedali Riuniti di Foggia
Phase
Phase 3
Overall status
Unknown status
Start date
November 5, 2019
Completion date
December 20, 2021
Enrollment
322 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spontaneous bacterial peritonitis